Corrective Phases R...
Health Care: Drugs
Corcept Therapeutics Inc. (CORT: NASDAQ)
$4.08 -0.01 | -0.24%
06/01/12 - 04:00 PM ET
Company Balance Sheet
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 39.64M | 24.58M | 23.87M | 14.72M |
| Receivables | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 39.78M | 25.00M | 24.42M | 19.58M |
| Property, Plant & Equipment, Gross | 76.00K | 51.00K | 51.00K | 51.00K |
| Accumulated Depreciation & Depletion | 50.00K | 47.00K | 41.00K | 31.00K |
| Property, Plant & Equipment, Net | 26.00K | 4.00K | 10.00K | 20.00K |
| Intangibles | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Assets | 32.00K | 104.00K | 81.00K | 176.00K |
| Total Non-Current Assets | 58.00K | 108.00K | 91.00K | 196.00K |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 39.83M | 25.10M | 24.51M | 19.78M |
| Accounts Payable | 3.61M | 817.00K | 1.27M | 1.30M |
| Short Term Debt | 0.00 | 0.00 | 6.00K | 10.00K |
| Other Current Liabilities | 533.00K | 422.00K | 224.00K | 316.00K |
| Total Current Liabilities | 5.03M | 3.86M | 2.42M | 2.86M |
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 6.00K |
| Total Liabilities | 5.03M | 3.86M | 2.42M | 2.87M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 34.81M | 21.24M | 22.09M | 16.91M |
| Common Par | 84.00K | 72.00K | 62.00K | 50.00K |
| Additional Paid In Capital | 243.28M | 197.47M | 172.37M | 153.03M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -208.56M | -176.20M | -150.24M | -130.07M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 0.00 | -97.00K | -101.00K | -6.10M |
| Total Capitalization | 34.81M | 21.24M | 22.09M | 16.91M |
| Total Equity | 34.81M | 21.24M | 22.09M | 16.91M |
| Total Liabilities & Stock Equity | 39.83M | 25.10M | 24.51M | 19.78M |
| Total Common Shares Outstanding | 84.23M | 72.40M | 62.48M | 49.76M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 83.31M | 68.34M | 52.44M | 46.72M |
| Diluted Weighted Shares Outstanding | 83.31M | 68.34M | 52.44M | 46.72M |
| Number of Employees | 31 | 31 | 27 | 28 |
| Number of Part-Time Employees | 5 | 4 | 3 | 3 |
Portfolios with CORT
- Portfolio NameUser Type
- Userwayne120
- Userespwes06 Portfolio 1
- ContributorStocks Under-$10 Moving Hig...
- ContributorTop 10 'Buy'-Rated Stocks U...
- ContributorBarron's Insider Purchases ...
- ContributorBarron's Insider Purchases ...
- Userrubylu02
- UserBarron's Insider Purchases ...
- Usermicahw29 Portfolio 1
- Userrktjky Portfolio 1
Latest CORT Headlines from TheStreet
- Corcept Has Upside Following Drug Approval 02.21.12 | 12:02 pm
- 7 Stocks Under $10 Moving Higher 02.16.12 | 02:02 pm
- These Drugs Stocks Will Win FDA Approval 02.16.12 | 12:02 pm
- Biotech Stock Mailbag: Corcept Therapeutics, Reader Retorts 02.10.12 | 07:02 am
- Play TheStreet's FDA Drug-Approval Contest 01.23.12 | 08:01 am
- 27 Hot Drugs Facing FDA Approval in 2012 12.19.11 | 10:12 am
- Biotech Calendar: Key Dates for March 03.02.11 | 08:03 am
- Danver Bancorp, Dean Foods: Small-Cap Winners 01.21.11 | 01:01 pm
- Biotech Calendar: Key Dates for December 11.30.10 | 07:11 am
- Novartis Cushing's Drug Passes Late-Stage Test 09.22.10 | 07:09 am
Press Releases for CORT
Partner Headlines for CORT
- Company News for February 22, 2012 - Corporate Summary - Zacks 02.22.12 | 10:02 am
- UPDATE: Stifel Nicolaus Increases Target to $9 on Concept Therepeutics - Benzinga 02.21.12 | 09:02 am
- 12 Healthcare Companies Expecting Major February Catalysts - Seeking Alpha 02.01.12 | 07:02 am
- Upcoming PDUFA Dates for Sub-$5 Stocks - Seeking Alpha 07.05.11 | 09:07 am
- 14 Oversold Stocks With Bearish Options - Seeking Alpha 07.01.11 | 08:07 am
- 10 Undervalued Biotech Stocks With Insider Buying - Seeking Alpha 06.23.11 | 06:06 am
- 7 Small-Cap Biotechs With Bullish Insider Buying in 2011 - Seeking Alpha 06.12.11 | 05:06 am
- Low Beta Ideas: 22 High Growth, Low Beta Stocks Being Snapped Up by Mutual Funds - Seeking Alpha 06.09.11 | 09:06 am
- Upgrades, Downgrades and Initiations for Monday - Seeking Alpha 06.06.11 | 09:06 am
- UPDATE 2-Corcept hormone disorder drug meets main trial goal - Reuters 12.22.10 | 11:12 am
